DataMeds AI (MEDS) Price to Sales (2025 - 2026)
DataMeds AI's (MEDS) quarterly Price to Sales came in at 7.35 in Q1 2026, down 69.93% on a YoY basis from 24.44 in Q1 2025, and down 56.76% quarter-over-quarter from 17.0 in Q4 2025.
Analysis
DataMeds AI (MEDS) Price to Sales (2025 - 2026) Analysis & Trends
DataMeds AI (MEDS) has reported Price to Sales for 2 consecutive years, with 7.35 the latest figure, recorded in Q1 2026.
- For the quarter ending Q1 2026, Price to Sales fell 69.93% year-over-year to 7.35; the trailing twelve-month figure through Mar 2026 stood at 0.82 (down 91.08% YoY), and the FY2025 full-year result was 1.22, changed N/A from the prior year.
- Price to Sales slipped to 7.35 in Q1 2026 per MEDS's latest filing, from 17.0 in the prior quarter.
- Across five years, Price to Sales topped out at 24.44 in Q1 2025 and bottomed at 7.35 in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Mckesson | 106.22 Bn | 101.06 Bn | 3.69 Bn |
| 2 | Cencora | 62.63 Bn | 59.81 Bn | 3.61 Bn |
| 3 | Cardinal Health | 56.55 Bn | 51.69 Bn | 2.56 Bn |
| 4 | Henry Schein | 9.98 Bn | 9.82 Bn | 1.10 Bn |
| 5 | ZeroStack | 42.33 Mn | 39.37 Mn | 1.62 Mn |
| 6 | 111 | 27.24 Mn | -27.13 Mn | 18.18 Mn |
| 7 | Guardian Pharmacy Services | 5.51 Mn | -84.30 Mn | 80.04 Mn |
| 8 | Ridgetech | 4.71 Mn | -13.30 Mn | - |
| 9 | MedWellAI | 2.27 Mn | 2.28 Mn | - |
| 10 | DataMeds AI | 1.78 Mn | 1.73 Mn | 170,221.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 7.35 |
| Dec 31, 2025 | 17.00 |
| Sep 30, 2025 | 21.90 |
| Jun 30, 2025 | 7.85 |
| Mar 31, 2025 | 24.44 |